Evidence map›Paper›PMID 36908627›Full record

ArticleFrontiers in neurology2023

Delivering acute stroke care in a middle-income country. The Mexican model: "ResISSSTE Cerebro".

Dulce María Bonifacio-Delgadillo, Enrique Castellanos-Pedroza, Bernardo Alfonso Martínez-Guerra, Claudia Marisol Sánchez-Martínez, Juan Manuel Marquez-Romero

Abstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dulce María Bonifacio-DelgadilloDepartment of Interventional Neurology, Centro Médico Nacional 20 de Noviembre Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado (ISSSTE), Mexico City, Mexico.
Enrique Castellanos-PedrozaDepartment of Interventional Neurology, Centro Médico Nacional 20 de Noviembre Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado (ISSSTE), Mexico City, Mexico.
Bernardo Alfonso Martínez-GuerraDepartament of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Claudia Marisol Sánchez-MartínezDepartment of Interventional Neurology, Centro Médico Nacional 20 de Noviembre Instituto de Seguridad y Servicios Sociales de Los Trabajadores del Estado (ISSSTE), Mexico City, Mexico.
Juan Manuel Marquez-RomeroDepartment of Neurology, Hospital General de Zona #2, Instituto Mexicano del Seguro Social (IMSS), Órganos de Operación Administrativa Desconcentrada (OOAD) Aguascalientes, Aguascalientes, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Founded in 2019, the "ResISSSTE Cerebro" program is the first and only stroke network within the Mexican public health system. One advanced stroke center (ASC) and seven essential stroke centers (ESC) provide acute stroke (AS) care through a modified hub-and-spoke model. This study describes the workflow, metrics, and outcomes in AS obtained during the program's third year of operation. Materials and methods: Participants were adult beneficiaries of the ISSSTE health system in Mexico City with acute focal neurological deficit within 24 h of symptom onset. Initial evaluation could occur at any facility, but the stroke team at the ASC took all decisions regarding treatment and transfers of patients. Registered variables included demographics, stroke risk factors, AS treatment workflow time points, and clinical outcome measures. Results: We analyzed data from 236 patients, 104 (44.3%) men with a median age of 71 years. Sixty percent of the patients were initially evaluated at the ESC, and 122 (85.9%) were transferred to the ASC. The median transfer time was 123 min. The most common risk factor was hypertension (73.6%). Stroke subtypes were ischemic (86.0%) and hemorrhagic (14.0%). Median times for onset-to-door, door-to-imaging, door-to-needle, and door-to-groin were: 135.5, 37.0, 76.0, and 151.5 min, respectively. The rate of intravenous thrombolysis was 35%. Large vessel occlusion was present in 63 patients, from whom 44% received endovascular therapy; 71.4% achieved early clinical improvement (median NIHSS reduction of 11 points). Treatment-associated morbimortality was 3.4%. Conclusion: With the implementation of a modified hub-and-spoke model, this study shows that delivery of AS care in low- and middle-income countries is feasible and achieves good clinical outcomes.

Indexed as

acute ischemic strokehub-and-spokelow- and middle-income countriespublic healthstroke centers

Identifiers

PMID36908627
PMCPMC9992879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.